Fundraising FoxRS Research
6 known investors
Find your way into RS Research
Sign up to see every warm intro you have to RS Research
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RS Research team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.
Founders & leadership
PR
Prof. Rana SanyalCo-Founder
Investors · 6
Also in the syndicate · 4
ACTEczacıbaşı MomentumGEN IlaçleadOneLife Ventures
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ADec 2021
GEN Ilaç (lead), ACT, Eczacıbaşı Momentum, OneLife Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does RS Research do?
- RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.
- Who founded RS Research?
- RS Research was founded by Prof. Rana Sanyal.
- Who are RS Research's investors?
- RS Research's investors include ACT Venture Partners, Eczacibasi Momentum Teknoloji Yatimlari.